The novel approach of this peptide represents a major advance in the care of type 2 diabetes. Different to existing medications, tirzepatide targets two pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – providing improved sugar control and potential weight loss. Experts are investigating its future benefits a